Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India
Shots:
- Lupin in collaboration with Aptar Pharma launch ADHERO- a smart device designed to help patients with chronic respiratory diseases by tracking MDI usage thus facilitate adherence to the therapy
- The launch will help patients utilizing MDI and HCPs to track adherence and compliance to therapy via patient’s dashboard as well as the app- thus lead to an improvement in clinical outcomes and QoL of patients
- ADHERO is a Bluetooth-enabled- reusable smart device- which patients can access by connecting their devices to the “MyAdhero” app on their smartphones. The app sends reminders- provide health alerts based on AQI at the patient’s current location and enable visual analytics
Click here to read full press release/ article | Ref: Lupin | Image: Pinterest
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com